术后观察重建并发症，局部肿瘤复发。
The postoperative complication of reconstruction and local recurrence were investigated.
结果8例诊断局部肿瘤复发。4例为瘢痕增生形成的肿块。
The results showed 8 cases were diagnosed as local recurrences of tumour and 4 cases as tumour caused by cicatrix accretion.
部分放射性损伤严重或有局部肿瘤复发的患者可以考虑行尿流改道手术。
Urinary diversion should be considered in patients with severe radioactive damage or local tumor relapse.
这种肿瘤具有侵袭性的临床病程，常出现局部复发和远处转移。
This tumour has an aggressive clinical course, with a high tendency for both local recurrence and distant metastasis.
观察肿瘤大小、局部复发和远处转移情况；
The size and shape, local recurrence and remote metastasis of the tumors were observed.
结论TME技术易于掌握，解剖层次清晰，肿瘤局部复发率低，值得临床推广应用。
Conclusion TME technology is easy to master, with clear anatomical level and low incidence of local tumor recurrence.
在随访期内，肱骨近端内固定假体置换能够提供良好的上肢功能，肿瘤局部复发率低，而且并发症发生率低。
Endoprosthetic replacement of the proximal humerus provides a good function of the upper limb, a low risk of local relapse with a low complication rate at follow-up.
气管、食管及颈总动脉受侵是姑息切除肿瘤的主要原因，局部复发是主要的死亡原因。
Tumor invasion in trachea, esophagus, and carotid are the main reasons of palliative surgery. Local relapse is lethal.
杀死或抑制肿瘤病灶，减少、迟局部复发或转移，改善预后，有着广阔发展前景。
It can kill or inhibit tumor cells, reduce or delay the chance of local recurrence or metastasis, and improve prognosis with a broad prospect.
这对于减少肿瘤的局部复发和远处转移，增加热凝固治疗抗肿瘤疗效具有重要的临床意义。
This change may play an important role clinically in reducing postoperative local recurrence and metastasis, and strengthening the therapeutic effects of thermal ablation on tumor.
结果：本组术后无外科并发症，平均随访10个月，无局部复发和肿瘤转移。
Results: There was no recurrence or tumor metastasis at a mean flow-up of 10 months.
这种肿瘤通常是良性的，很少会侵入脑实质或局部复发。
These tumors are typically benign and rarely invade brain parenchyma or develop local recurrence.
结果治疗后大部分患者临床指标明显改善，肢体肿瘤患者92％行保肢手术，术后局部复发率为13．6％。
Results Marked improvement of the symptoms in most patients were noticed. Limb sparing resection was obtained in 92% patients and the local recurrence rate was 13.6%.
但有时肿瘤会扩散到身体其他部位，以及局部对放疗不敏感而复发。
But sometimes the cancers spread to other parts of the body or partially resist radiation and grow back later.
多数学者认为局部复发、术前是否存在转移、术后残存肿瘤体积以及患者年龄等因素都对预后有显著影响。
Factors which include local relapse, whether or not there has occurred metastases before resection, residual tumor and age etc. are mostly considered to have significant effects on prognosis.
原发肿瘤大小、病理组织学类型、腋淋巴结阳性数是影响局部复发的主要因素。
Tumor size, histopathological type, number of positive axillary lymph nodes are the main factors influencing local recurrence.
结论鳞样小汗腺导管癌是一种非常罕见的低度恶性肿瘤，局部切除后可复发，未见转移报道。
Conclusions Squamoid eccrine ductal carcinoma is an exceedingly rare low-grade malignant tumor and can recur after excision but do not metastasize.
放、化疗作为骨外骨肉瘤的辅助治疗方法，在提高肿瘤的切除率和减少局部复发和远处转移等方面有帮助。
Radiotherpy and chemotherapy play an adjuvant role in the treatment of EOS, improve the resection rate and reduce the recurrence and metastasis.
食管癌放疗失败的主要原因是肿瘤局部复发。
观察组织消融范围、肿瘤完全消融率和局部复发率。
The ablated area, complete ablation rate and local recurrence were evaluated.
术后平均随访26（3~57）个月，未见并发症及肿瘤局部复发及转移。
The patients had were followed up for 3 to 57 months (mean 26 months) with no surgical complication or local tumor recurrence.
背景：骨巨细胞瘤是一种常见的骨肿瘤，其有较强的局部侵蚀性，术后复发率较高。
Background: Giant cell tumor of bone (GCT) is frequently seen in bone tumors, with local aggression and high risk of recurrence.
评价结果包括局部复发，远处复发，肿瘤特异性生存率。
Outcomes evaluated included local recurrence, distant recurrence, and cancer specific survival.
术后局部复发或远处转移情形，偶发性肾肿瘤比有症状的肾肿瘤低（6.9%比30.2%）。
Postoperatively, there was local tumor recurrence or distal metastasis in 6.9% of patients with incidental RCC and 30.2% of symptomatic patients.
彻底切除肿瘤能有效避免复发，对于无法全切除或复发性肿瘤患者，术后常规行局部放疗。
For patients who suffered from recurrence tumors or those who can not adopt total-excision treatment, we can adopt radiotherapy after the operation.
由于单纯手术治疗的局部、区域和全身的复发率较高，化疗和放疗已经成为这一肿瘤综合治疗的一部分。
Because of the high rate of locoregional and systemic recurrence with surgery alone, chemotherapy and radiation therapy have become integrated into the management of gastric cancer.
MTT与肿瘤局部复发之间相关性没有明显统计学意义。
There was no statistically significance between MTT and local recurrences.
认为本术的切除范围有利于预防肿瘤的局部复发。
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
应用推荐